Vaxxinity Inc. Class AVAXX

13F holders, Q1 2025 (March 31)
1holders −7
1new positions
0sold out
$1.00avg. 13F price*

At the end of Q1 2025, 1 institutions reported holding Vaxxinity Inc. Class A (VAXX) in their 13F filings, down 7 from Q2 2024. 1 opened new positions and 0 sold out. The largest holder was Crossingbridge Advisors, LLC ($1K).

Company
Vaxxinity Inc. Class A
CUSIP
92244V104
Latest filing quarter
Q1 2026

History

Number of 13F holders

0204060 Q1 2024: 58Q1 2024Q2 2024: 8Q2 2024Q1 2025: 1Q1 2025Q3 2025: 1Q3 2025Q1 2026: 1Q1 2026

Total Exit/New Position Q2 2024 → Q1 2025

InstitutionsTotal Value
New Positions1$1K
Exits0$0

All 13F filers, Q2 2024 → Q1 2025: 1,418 shares bought, net +1,418 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 1 holders

Crossingbridge Advisors, LLC 0.00% New 1,418 $1K

"% of holder's portfolio" is VAXX's weight in each manager's 13F, not the share of Vaxxinity Inc. Class A the manager owns.